Group items tagged

Surrogate motherhood history dates back to biblical times, some say it all started with Sarah and Abraham, others say it was around even before them, just they were the only ones recorded about it because of Abraham being in the bible. In countries all over the world the history of surrogate mothers dates back further than we can recall. Many cultures beliefs include surrogacy as a way of life, and those who don't abide by it are banned from their families. Many religions and cultures today believe the surrogates themselves are martyrs for their beliefs; their good deeds and overall intentions go unnoticed by many. In the 1980's the gay community took on the use of surrogates to form families for themselves; which was frowned upon then. If you really look at the history of surrogacy, aside from biblical times, it really began in the late 1800's with the Indians (which are just one culture.) If an Indian woman was found to be baron, the husband would go to the chief and inform the chief of this problem. The chief would then advise the husband to counsel with the witch doctor/ medicine man. After several attempts with medicine if the woman was still found to be baron, the chief would allow for the husband to consort with another female who was baron so that the husband would have a son to carry on his tribe; surrogacy then was not in vitro, rather, the male would have to have relations with the other female… the wife would have no biological ties to the child. But the Indians were not the only culture to use surrogacy as a means to carry on the family name. It's been known about throughout Europe and Spain and other such places. Kings would often bring in several surrogates until one bore him a son, then the surrogates would be kept as nannies to the child; the child would believe the King and Queen were its biological parents and know nothing about its genetic ties to the nanny. Often things of this matter were kept in close regard because if such thing

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that